RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:$3The only new info with regards to ACTG is that they have begun in earnest to monetize their IP. Unknown tho is that they acquired a bunch of bio/medical companies and are offloading some of them. There should be more color, as the analysts call it, at ACTG's Q4 conference call.